Table 1.
Patient demographics.
| Characteristic |
Placebo (n = 27) |
Luvadaxistat 75 mg BID (n = 14) |
Luvadaxistat 300 mg BID (n = 26) |
|---|---|---|---|
| Mean age at screening, years (SD) | 32.5 (11.0) | 31.1 (11.3) | 29.6 (8.9) |
| Sex, n (%) | |||
| Female | 17 (63.0) | 5 (35.7) | 15 (57.7) |
| Male | 10 (37.0) | 9 (64.3) | 11 (42.3) |
| Mean body mass index, kg/m2 (SD) | 24.9 (4.9) | 24.9 (4.4) | 23.0 (3.9) |
| Ambulation status, n (%) | |||
| Ambulatory | 12 (44.4) | 6 (42.9) | 12 (46.2) |
| Non‐ambulatory | 15 (55.6) | 8 (57.1) | 14 (53.8) |
BID, twice daily; SD, standard deviation.